242 related articles for article (PubMed ID: 9757169)
1. Relation between severity of Alzheimer's disease and costs of caring.
Hux MJ; O'Brien BJ; Iskedjian M; Goeree R; Gagnon M; Gauthier S
CMAJ; 1998 Sep; 159(5):457-65. PubMed ID: 9757169
[TBL] [Abstract][Full Text] [Related]
2. The cost of Alzheimer's disease in managed care: a cross-sectional study.
Leon J; Neumann PJ
Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease: the burden of the illness in England.
Gray A; Fenn P
Health Trends; 1993; 25(1):31-7. PubMed ID: 10171428
[TBL] [Abstract][Full Text] [Related]
4. Canadian study of health and aging: study methods and prevalence of dementia.
CMAJ; 1994 Mar; 150(6):899-913. PubMed ID: 8131123
[TBL] [Abstract][Full Text] [Related]
5. Net economic costs of dementia in Canada.
Ostbye T; Crosse E
CMAJ; 1994 Nov; 151(10):1457-64. PubMed ID: 7954140
[TBL] [Abstract][Full Text] [Related]
6. Assessing the societal impact of acetylcholinesterase inhibitor therapies.
Winblad B; Wimo A
Alzheimer Dis Assoc Disord; 1999 Nov; 13 Suppl 2():S9-19. PubMed ID: 10622674
[TBL] [Abstract][Full Text] [Related]
7. [Model of costs of care for dementia: community-dwelling vs. institutionalization].
van der Roer N; Goes ES; Blom M; Busschbach JJ
Tijdschr Gerontol Geriatr; 2000 Apr; 31(2):55-61. PubMed ID: 10816892
[TBL] [Abstract][Full Text] [Related]
8. Economic considerations in Alzheimer's disease.
Meek PD; McKeithan K; Schumock GT
Pharmacotherapy; 1998; 18(2 Pt 2):68-73; discussion 79-82. PubMed ID: 9543467
[TBL] [Abstract][Full Text] [Related]
9. Community care for patients with Alzheimer's disease and non-demented elderly people: use and satisfaction with services and unmet needs in family caregivers.
Dello Buono M; Busato R; Mazzetto M; Paccagnella B; Aleotti F; Zanetti O; Bianchetti A; Trabucchi M; De Leo D
Int J Geriatr Psychiatry; 1999 Nov; 14(11):915-24. PubMed ID: 10556862
[TBL] [Abstract][Full Text] [Related]
10. Estimating the costs of caring for people with Alzheimer disease in California: 2000-2040.
Fox PJ; Kohatsu N; Max W; Arnsberger P
J Public Health Policy; 2001; 22(1):88-97. PubMed ID: 11382092
[TBL] [Abstract][Full Text] [Related]
11. Potential effect of tacrine on expenditures for Alzheimer's disease.
Lubeck DP; Mazonson PD; Bowe T
Med Interface; 1994 Oct; 7(10):130-8. PubMed ID: 10172130
[TBL] [Abstract][Full Text] [Related]
12. The economic burden of Alzheimer's disease in Israel.
Rothstein Z; Prohovnik I; Davidson M; Beeri MS; Noy S
Isr J Med Sci; 1996 Nov; 32(11):1120-3. PubMed ID: 8960086
[TBL] [Abstract][Full Text] [Related]
13. The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy.
Cavallo MC; Fattore G
Alzheimer Dis Assoc Disord; 1997 Dec; 11(4):184-90. PubMed ID: 9437435
[TBL] [Abstract][Full Text] [Related]
14. The health economics of Alzheimer's disease.
Nurs Stand; 1998 Apr 29-May 5; 12(32):32-3. PubMed ID: 9668823
[No Abstract] [Full Text] [Related]
15. Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine.
Hauber AB; Gnanasakthy A; Snyder EH; Bala MV; Richter A; Mauskopf JA
Pharmacoeconomics; 2000 Apr; 17(4):351-60. PubMed ID: 10947490
[TBL] [Abstract][Full Text] [Related]
16. An economic perspective on Alzheimer's disease.
Trabucchi M
J Geriatr Psychiatry Neurol; 1999; 12(1):29-38. PubMed ID: 10447152
[TBL] [Abstract][Full Text] [Related]
17. A multidisciplinary team approach to managing Alzheimer's disease.
Beck CK; Cody M; Zhang M
Pharmacotherapy; 1998; 18(2 Pt 2):33-42; discussion 79-82. PubMed ID: 9543463
[TBL] [Abstract][Full Text] [Related]
18. The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer's disease.
Davis KL; Marin DB; Kane R; Patrick D; Peskind ER; Raskind MA; Puder KL
Int J Geriatr Psychiatry; 1997 Oct; 12(10):978-88. PubMed ID: 9395929
[TBL] [Abstract][Full Text] [Related]
19. Rivastigmine for Alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications.
Baladi JF; Bailey PA; Black S; Bouchard RW; Farcnik KD; Gauthier S; Kertesz A; Mohr E; Robillard A
Clin Ther; 2000 Dec; 22(12):1549-61. PubMed ID: 11192146
[TBL] [Abstract][Full Text] [Related]
20. [Costs of health care resources of ambulatory-care patients diagnosed with Alzheimer's disease in Spain].
Boada M; Peña-Casanova J; Bermejo F; Guillén F; Hart WM; Espinosa C; Rovira J
Med Clin (Barc); 1999 Nov; 113(18):690-5. PubMed ID: 10650570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
